Beyond Consensus: Translating the APLAR Reproductive Rheumatology Recommendations Into Measurable Care Across the Asia‐Pacific Region
- 5 November 2026
- journal article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (11)
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 updateAnnals of the Rheumatic Diseases, 2025
- Access to rheumatologic care in tropical regions: Barriers and solutionsBest Practice & Research Clinical Rheumatology, 2025
- British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsRheumatology, 2022
- Changes to expert opinion in the use of antirheumatic drugs before and during pregnancy five years after EULAR: points to considerRheumatology, 2022
- Managing puerperium in patients with systemic autoimmune diseases: an updateExpert Review of Clinical Immunology, 2022
- Exploring the Preferences of Women Regarding Sexual and Reproductive Health Care in the Context of Rheumatology: A Qualitative StudyArthritis Care & Research, 2021
- The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic reviewHuman Reproduction Update, 2020
- Postnatal Care of Woman with Rheumatic DiseasesAdvances in Therapy, 2020
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal DiseasesArthritis & Rheumatology, 2020
- An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseasesRheumatology Advances in Practice, 2019